Walter & Keenan Wealth Management LLC Bristol Myers Squibb CO Transaction History

Walter & Keenan Wealth Management LLC

$304 Million
Q1 2024

A detailed history of Walter & Keenan Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Walter & Keenan Wealth Management LLC holds 10,206 shares of BMY stock, worth $404,769. This represents 0.18% of its overall portfolio holdings.

Number of Shares

10,206

Previous 9,064 12.6%

Holding current value

$404,769

Previous $465,000 18.92%

% of portfolio

0.18%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $54,793 - $62,124	1,142 Added 12.6%	10,206 $553,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $33,936 - $40,495	-700 Reduced 7.17%	9,064 $465,000
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $2,257 - $2,524	39 Added 0.4%	9,764 $566,000
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $4,778 - $5,305	75 Added 0.78%	9,725 $621,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $361,404 - $409,915	-5,500 Reduced 36.3%	9,650 $668,000

Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $37,664 - $44,599	550 Added 3.77%	15,150 $1.09 Million
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $65 - $38,727	504 Added 3.58%	14,600 $1.04 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $30,863 - $33,991	-425 Reduced 2.93%	14,096 $1.09 Million
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $55,915 - $65,497	945 Added 6.96%	14,521 $859,000
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $196,564 - $214,058	3,175 Added 30.53%	13,576 $907,000
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $47,472 - $53,391	-800 Reduced 7.14%	10,401 $657,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 Added 0.9%	11,201 $695,000
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $2,641 - $2,927	-46 Reduced 0.41%	11,101 $669,000
Q2 2020 Jul 16, 2020	BUY	$54.82 - $64.09 $611,078 - $714,411	11,147 New	11,147 $655,000
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $515,086 - $748,540	-11,101 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $18,699 - $24,392	380 Added 3.54%	11,101 $713,000
Q3 2019 Oct 28, 2019	BUY	$42.77 - $50.71 $67,148 - $79,614	1,570 Added 17.16%	10,721 $544,000
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $22,310 - $24,670	500 Added 5.78%	9,151 $415,000
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $9,069 - $10,813	201 Added 2.38%	8,651 $413,000
Q3 2018 Oct 29, 2018	SELL	$55.19 - $62.25 $8,278 - $9,337	-150 Reduced 1.74%	8,450 $525,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $7,579 - $9,447	150 Added 1.78%	8,600 $476,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $466,693 - $538,603	8,450	8,450 $559,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walter & Keenan Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Walter & Keenan Wealth Management LLC with notifications on news.

Account

Walter & Keenan Wealth Management LLC Bristol Myers Squibb CO Transaction History